The Natural Progression of Gambiense Sleeping Sickness: What Is the Evidence?
Open Access
- 23 December 2008
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLoS Neglected Tropical Diseases
- Vol. 2 (12), e303
- https://doi.org/10.1371/journal.pntd.0000303
Abstract
Gambiense human African trypanosomiasis (HAT, sleeping sickness) is widely assumed to be 100% pathogenic and fatal. However, reports to the contrary exist, and human trypano-tolerance has been postulated. Furthermore, there is uncertainty about the actual duration of both stage 1 and stage 2 infection, particularly with respect to how long a patient remains infectious. Understanding such basic parameters of HAT infection is essential for optimising control strategies based on case detection. We considered the potential existence and relevance of human trypano-tolerance, and explored the duration of infectiousness, through a review of published evidence on the natural progression of gambiense HAT in the absence of treatment, and biological considerations. Published reports indicate that most gambiense HAT cases are fatal if untreated. Self-resolving and asymptomatic chronic infections probably constitute a minority if they do indeed exist. Chronic carriage, however, deserves further study, as it could seed renewed epidemics after control programmes cease.Keywords
This publication has 90 references indexed in Scilit:
- Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next?PLoS Medicine, 2008
- Estimates of the duration of the early and late stage of gambiense sleeping sicknessBMC Infectious Diseases, 2008
- Evolution of parasite virulence when host responses cause diseaseProceedings Of The Royal Society B-Biological Sciences, 2007
- Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine proteaseJCI Insight, 2006
- A Gambian Infant with Fever and an Unexpected Blood FilmPLoS Medicine, 2006
- Diagnosing human African trypanosomiasis in Angola using a card agglutination test: observational study of active and passive case finding strategiesBMJ, 2006
- Clinical and serologic responses to human ‘apathogenic’ trypanosomesTransactions of the Royal Society of Tropical Medicine and Hygiene, 2005
- The rate of antigenic variation in fly-transmitted and syringe-passaged infections of Trypanosoma bruceiFEMS Microbiology Letters, 1997
- Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sicknessThe Lancet, 1992
- Is Trypanosoma brucei an intracellular parasite?Parasitology Today, 1986